Gary Ablett Jr. Gets His Gameday On
Brownlow medallist and dual AFL premiership player Gary Ablett Jr. has joined Gameday International, a wholly owned subsidiary of Impression Healthcare (ASX:IHL) as its latest ambassador.
The AFL legend who has captained the Gold Coast Suns since his departure from Geelong Football Club in 2010, will promote Gameday via advertising and other marketing activities to build brand awareness around Gameday Mouthguards and future products.
Gameday manufactures custom mouthguards at an affordable price making them accessible to all Australian sports participants.
However it is still an early stage company and investors considering this stock for their portfolio, should seek professional financial advice.
It expected Ablett’s involvement will bring awareness through the entire AFL community, from grassroots level to more senior leagues.
The eight-time All-Australian will be looked upon to promote a message of safe play through grass roots media related activity, as well as the benefits of wearing a custom-made mouthguard.
Ablett will attend school clinics and use social media to work with Gameday to produce and promote a limited edition mouthguard to be named after the champion: Gary Ablett Jnr. Limited Edition Mouthguards.
“I’m incredibly excited to be involved with Gameday. Gameday’s custom-fit mouthguards are an incredible product, providing an affordable high quality option for all the players out there who should be wearing protective mouthguards when playing sports. As someone how is passionate about encouraging children to play Australian Rules Football, it’s really important to promote the message of safe play and mouthguard use at the same time.”
Ablett’s signing comes just weeks after two prominent players from the AFLW signed on as Gameday ambassadors.
Ablett will join high profile professional women’s AFL players, Moana Hope and Kaitlyn Ashmore, as Gameday’s AFL representatives.
The AFLW players joined Gameday just as IHL debuted on the ASX in November.
As part of his consideration, Ablett will be issued with 625,000 shares in Impression Healthcare, further aligning his interests with the company.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.